UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets

PloS one, 2017-10, Vol.12 (10), p.e0187262-e0187262

2017

Volltextzugriff (PDF)

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical cancer research, 2021-04, Vol.27 (8), p.2190-2199

2021

Volltextzugriff (PDF)

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Clinical cancer research, 2017-02, Vol.23 (4), p.1068-1079

2017

Volltextzugriff (PDF)

Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study

The Lancet. Haematology, 2021-11, Vol.8 (11), p.e808-e817

2021

Volltextzugriff (PDF)

How to express mental health problems: Turkish immigrants in Berlin compared to native Germans in Berlin and Turks in Istanbul

European psychiatry, 2012-06, Vol.27, p.S50-S55

2012

Volltextzugriff (PDF)

Mental disorders of immigrants in Germany

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2015-06, Vol.58 (6), p.527-532

2015

Volltextzugriff (PDF)

The concept of “intercultural opening”: the development of an assessment tool for the appraisal of its current implementation in the mental health care system

European psychiatry, 2012-06, Vol.27, p.S63-S69

2012

Volltextzugriff (PDF)

MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

Journal of molecular neuroscience, 2003-04, Vol.20 (2), p.173-188

2003

Volltextzugriff (PDF)

Microcontacts with sub-30 μm pitch for 3D chip-on-chip integration

Microelectronic engineering, 2006-11, Vol.83 (11), p.2155-2162

2006

Volltextzugriff (PDF)

Understanding and Managing Socioeconomic Systems Behaviour: Applications of Qualitative and Quantitative System Dynamics and Agent-Based Modelling in Healthcare and Pharmaceuticals, Finance, Arts and Culture, Sociology and Education Systems

1, 2024

Volltextzugriff (PDF)

Maintenance treatment in opioid-dependent patients with migration background

Nervenarzt, 2016-05, Vol.87 (5), p.521-527

2016

Volltextzugriff (PDF)

Explanatory models of addictive behaviour among native German, Russian-German, and Turkish youth

European psychiatry, 2008, Vol.23 (S1), p.36-42

2008

Volltextzugriff (PDF)

Patients of immigrant origin in inpatient psychiatric facilities. A representative national survey by the Psychiatry and Migration Working Group of the German Federal Conference of Psychiatric Hospital Directors

European psychiatry, 2008-01, Vol.23 Suppl 1 (S1), p.21-s27

2008

Volltextzugriff (PDF)

Patients of immigrant origin in inpatient psychiatric facilities

European psychiatry, 2008, Vol.23, p.21-27

2008

Volltextzugriff (PDF)

Psychische Störungen bei Menschen mit Migrationshintergrund in Deutschland

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2015, Vol.58 (6), p.527-532

2015

Volltextzugriff (PDF)

Patients of immigrant origin in inpatient psychiatric facilities. Differences between first and second generation: nationwide questionnaire of the Psychiatry and Migration Working Group of the German Federal Conference of Psychiatric Hospital Directors

Nervenarzt, 2010-01, Vol.81 (1), p.86-94

2010

Volltextzugriff (PDF)

CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

Blood, 2021-11, Vol.138 (Supplement 1), p.3560-3560

2021

Volltextzugriff (PDF)

Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL

Blood, 2017-12, Vol.130, p.3886-3886

2017

Volltextzugriff (PDF)

Scalar Implicatures

2019

Volltextzugriff (PDF)

Abstract 2720: The CD47-blocking innate immune checkpoint inhibitor, TTI-621, triggers CD47-mediated tumor cell apoptosis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2720-2720

2018

Volltextzugriff (PDF)

Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases

Progress in Brain Research, 2004, Vol.146, p.167-183

2004

Volltextzugriff (PDF)

Investigating the Effects of Anti-CD200 Therapy for Childhood ALL

Blood, 2016-12, Vol.128 (22), p.4021-4021

2016

Volltextzugriff (PDF)

Abstract 5011: Cancer immunotherapy targeting CD47: Wild type SIRPαFc is the ideal CD47-blocking agent to minimize unwanted erythrocyte binding

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5011-5011

2014

Volltextzugriff (PDF)

1 – 25 von 1.690

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.240)
Mit Volltextzugriff
(1.295)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(640)
Life Sciences & Biomedicine
(462)
Humans
(359)
Female
(191)
Male
(183)
Physical Sciences
(145)
Middle Aged
(117)
Adult
(115)
Social Sciences
(104)
Chemistry
(98)
Biological And Medical Sciences
(88)
Technology
(81)
Aged
(78)
Animals
(74)
History
(65)
Fundamental And Applied Biological Sciences. Psychology
(56)
Physics
(56)
Biochemistry & Molecular Biology
(55)
Neurosciences & Neurology
(50)
Risk Factors
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(25)

Menü

Weitere Dienste

Einstellungen

TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study

How to express mental health problems: Turkish immigrants in Berlin compared to native Germans in Berlin and Turks in Istanbul

Mental disorders of immigrants in Germany

The concept of “intercultural opening”: the development of an assessment tool for the appraisal of its current implementation in the mental health care system

MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

Microcontacts with sub-30 μm pitch for 3D chip-on-chip integration

Understanding and Managing Socioeconomic Systems Behaviour: Applications of Qualitative and Quantitative System Dynamics and Agent-Based Modelling in Healthcare and Pharmaceuticals, Finance, Arts and Culture, Sociology and Education Systems

Maintenance treatment in opioid-dependent patients with migration background

Explanatory models of addictive behaviour among native German, Russian-German, and Turkish youth

Patients of immigrant origin in inpatient psychiatric facilities. A representative national survey by the Psychiatry and Migration Working Group of the German Federal Conference of Psychiatric Hospital Directors

Patients of immigrant origin in inpatient psychiatric facilities

Psychische Störungen bei Menschen mit Migrationshintergrund in Deutschland

Patients of immigrant origin in inpatient psychiatric facilities. Differences between first and second generation: nationwide questionnaire of the Psychiatry and Migration Working Group of the German Federal Conference of Psychiatric Hospital Directors

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL

Scalar Implicatures

Abstract 2720: The CD47-blocking innate immune checkpoint inhibitor, TTI-621, triggers CD47-mediated tumor cell apoptosis

Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases

Investigating the Effects of Anti-CD200 Therapy for Childhood ALL

Abstract 5011: Cancer immunotherapy targeting CD47: Wild type SIRPαFc is the ideal CD47-blocking agent to minimize unwanted erythrocyte binding

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Suchergebnisse filtern